MYLAN 152 (Clonidine 0.1 mg)
Pill imprint MYLAN 152 has been identified as Clonidine hydrochloride 0.1 mg.
Clonidine is used in the treatment of opiate withdrawal; adhd; anxiety; benzodiazepine withdrawal; restless legs syndrome (and more), and belongs to the drug class antiadrenergic agents, centrally acting. Risk cannot be ruled out during pregnancy. Clonidine 0.1 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).
- 0.1 mg
- 6.00 mm
- Prescription only
sodium lauryl sulfate
|NDC Code||Manufacturer / Repackager|
|51079-0299||UDL Laboratories Inc|
|54569-0478||A-S Medication Solutions, LLC (repackager)|
|00615-2572||Vangard Labs Inc (repackager)|
|68115-0087||Dispensexpress Inc (repackager)|
|54868-0048||Physicians Total Care Inc (repackager)|
|49999-0127||Lake Erie Medical and Surgical Supply (repackager)|
|63874-0475||Altura Pharmaceuticals Inc (repackager)|
|23490-5351||Palmetto State Pharmaceuticals Inc (repackager)|
Note: Inactive ingredients may vary.
More about clonidine
- Clonidine extended-release tablets
- Clonidine patches
- Clonidine suspension
- Clonidine tablets
- Clonidine transdermal
- More (3) »
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.